Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study

Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara, Kota Ohuchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka Department of Medical Oncology, Tohoku Unive...

Bibliografski detalji
Glavni autori:	Imai H, Saijo K, Komine K, Ueta R, Numakura R, Wakayama S, Umegaki S, Hiraide S, Kawamura Y, Kasahara Y, Ohuchi K, Takahashi M, Takahashi S, Shirota H, Ishioka C
Format:	Članak
Jezik:	English
Izdano:	Dove Medical Press 2022-03-01
Serija:	Cancer Management and Research
Teme:	gastric cancer chemotherapy oxaliplatin antibiotics
Online pristup:	https://www.dovepress.com/antibiotic-treatment-improves-the-efficacy-of-oxaliplatin-based-therap-peer-reviewed-fulltext-article-CMAR

Slični predmeti

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
od: Mohammad Ali Mashhadi, i dr.
Izdano: (2016-10-01)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
od: Guoxiu Wang, i dr.
Izdano: (2018-05-01)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
od: Yuanyuan Yu, i dr.
Izdano: (2021-05-01)

Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
od: Fei-Yu Wang, i dr.
Izdano: (2025-03-01)

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
od: Qian J, i dr.
Izdano: (2016-02-01)

Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center
od: Yung-Chia Kuo, i dr.
Izdano: (2014-06-01)

S-1 and oxaliplatin regimen neoadjuvant chemotherapy followed by surgery for resectable advanced gastric cancer with multiple lymph-node metastasis
od: T. Udaka, i dr.
Izdano: (2022-05-01)

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
od: Imai H, i dr.
Izdano: (2018-09-01)

Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
od: Masato Kondo, i dr.
Izdano: (2020-06-01)

Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
od: Xinxin Wang, i dr.
Izdano: (2024-04-01)

Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis
od: Peijie Lei, i dr.
Izdano: (2024-05-01)

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
od: Yasuyuki Kawamoto, i dr.
Izdano: (2017-12-01)

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol
od: Tsutomu Namikawa, i dr.
Izdano: (2018-02-01)

Oxaliplatin-Associated Amaurosis Fugax
od: Kimitoshi Kubo, i dr.
Izdano: (2021-06-01)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
od: Hirokazu Shoji, i dr.
Izdano: (2021-08-01)

A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
od: Ezanno Anne-Cecile, i dr.
Izdano: (2022-01-01)

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
od: Nobuaki Egashira, i dr.
Izdano: (2021-09-01)

Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
od: Qixuan Xu, i dr.
Izdano: (2024-08-01)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
od: Kabsoo Shin, i dr.
Izdano: (2019-12-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
od: Xinyu Guo, i dr.
Izdano: (2025-01-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients' FOXP1 and GGT levels
od: Xinyu Guo, i dr.
Izdano: (2024-11-01)

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
od: Xinxin Wang, i dr.
Izdano: (2021-01-01)

Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population
od: Jian JIANG, i dr.
Izdano: (2009-10-01)

PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis
od: Xiaoyu Guo, i dr.
Izdano: (2022-08-01)

Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study
od: Imai H, i dr.
Izdano: (2019-08-01)

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy
od: Hiroshi Saeki, i dr.
Izdano: (2018-01-01)

Establishment of the menthol test as a clinical evaluation method for oxaliplatin-induced neuropathy
od: Yeongcheol Cheong, i dr.
Izdano: (2022-08-01)

Oxaliplatin Promotes Apoptosis of Gastric Cancer Cell Line SGC-7901 by Regulating miRNA-7-5p/RAF-1
od: GU Zehui, i dr.
Izdano: (2020-03-01)

Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications
od: Sijia Zhong, i dr.
Izdano: (2024-09-01)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
od: Qing-nan Zhou, i dr.
Izdano: (2023-05-01)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
od: Hiroaki Tanioka, i dr.
Izdano: (2019-10-01)

Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response
od: Ying Tan, i dr.
Izdano: (2022-08-01)

Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
od: Jianming Xu, i dr.
Izdano: (2021-01-01)

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
od: Elizabeth Pan, i dr.
Izdano: (2018-12-01)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
od: Yu S, i dr.
Izdano: (2020-10-01)

A case of tongue swelling after S-1, oxaliplatin, and trastuzumab for HER2-positive gastric cancer
od: Taichi Abe, i dr.
Izdano: (2023-11-01)

Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
od: Akihiko Hatano, i dr.
Izdano: (2023-11-01)

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
od: Diana Groza, i dr.
Izdano: (2018-05-01)

Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy
od: Yixin Yin, i dr.
Izdano: (2022-09-01)

Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report
od: Zhen Wang, i dr.
Izdano: (2024-11-01)